title: Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.
abstract: OBJECTIVE
  Although pulmonary rehabilitation is effective for patients with COPD, its efficacy in patients with IPF is unknown. The purpose of this study was to evaluate the effects of pulmonary rehabilitation in IPF.
  
  
  METHODS
  Thirty patients diagnosed with IPF, according to the consensus statement, were randomly assigned to the rehabilitation group or the control group. The pulmonary rehabilitation mainly consisted of a 10-week programme of exercise training. Pulmonary function, blood gas analysis, 6MWD, dyspnoea rating with the baseline dyspnoea index and health-related quality of life score on the St George's Respiratory Questionnaire were evaluated at baseline and after the programme.
  
  
  RESULTS
  Assessment of efficacy was carried out on 13 patients who completed the programme and 15 patients in the control group. There were no significant effects of the programme on measures of pulmonary function, values of arterial blood gas analysis or dyspnoea rating. Although there were some differences in the baseline 6MWD and total health-related quality of life score which were not statistically significant, marked improvements were observed in the 6MWD (mean difference 46.3 m (95% CI: 8.3-84.4), P < 0.05) and the total health-related quality of life score (-6.1 (95% CI: -11.7 to -0.5), P < 0.05).
  
  
  CONCLUSIONS
  Pulmonary rehabilitation improves both exercise capacity and health-related quality of life in patients with IPF.
authors.affiliation: Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto Aichi, Japan.
authors.forename: Osamu
authors.initials: O
authors.lastname: Nishiyama
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Kondoh
authors.forename: Tomoki
authors.initials: T
authors.lastname: Kimura
authors.forename: Keisuke
authors.initials: K
authors.lastname: Kato
authors.forename: Kensuke
authors.initials: K
authors.lastname: Kataoka
authors.forename: Tomoya
authors.initials: T
authors.lastname: Ogawa
authors.forename: Fumiko
authors.initials: F
authors.lastname: Watanabe
authors.forename: Shinichi
authors.initials: S
authors.lastname: Arizono
authors.forename: Koichi
authors.initials: K
authors.lastname: Nishimura
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Taniguchi
mesh_terms: D000368:Aged; D001784:Blood Gas Analysis; D004417:Dyspnea / Q000503:physiopathology; D015444:Exercise / Q000502:physiology; D005081:Exercise Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000503:physiopathology / Q000534:rehabilitation* / Q000628:therapy*; D011788:Quality of Life; D012129:Respiratory Function Tests; D012720:Severity of Illness Index; D016896:Treatment Outcome